Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Social Feedback on Personal Goals
NCT02740101Phase 1Completed
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Nov 2014
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Social Anxiety Disorder (SAD) and Autism Spectrum Disorder (ASD) comparing oxytocin nasal spray with placebo nasal spray (2 arms). Primary endpoint: Rating of Encouragement at 1 hour. Started Nov 2014; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Social Anxiety Disorder (SAD)Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02740101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740101.